Compare ALEMBIC PHARMA with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DIVIS LABORATORIES ALEMBIC PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 29.0 40.3 71.9% View Chart
P/BV x 2.9 11.1 26.2% View Chart
Dividend Yield % 1.8 0.5 358.8%  

Financials

 ALEMBIC PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
DIVIS LABORATORIES
Mar-21
ALEMBIC PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,1503,913 29.4%   
Low Rs5271,824 28.9%   
Sales per share (Unadj.) Rs274.4262.5 104.5%  
Earnings per share (Unadj.) Rs56.774.7 75.9%  
Cash flow per share (Unadj.) Rs66.084.4 78.3%  
Dividends per share (Unadj.) Rs14.0020.00 70.0%  
Avg Dividend yield %1.70.7 239.5%  
Book value per share (Unadj.) Rs260.9350.1 74.5%  
Shares outstanding (eoy) m196.56265.47 74.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.110.9 28.0%   
Avg P/E ratio x14.838.4 38.5%  
P/CF ratio (eoy) x12.734.0 37.3%  
Price / Book Value ratio x3.28.2 39.2%  
Dividend payout %24.726.8 92.3%   
Avg Mkt Cap Rs m164,818761,517 21.6%   
No. of employees `000NANA-   
Total wages/salary Rs m10,5128,258 127.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,93169,694 77.4%  
Other income Rs m875627 139.6%   
Total revenues Rs m54,80670,321 77.9%   
Gross profit Rs m14,80128,611 51.7%  
Depreciation Rs m1,8352,556 71.8%   
Interest Rs m16021 762.9%   
Profit before tax Rs m13,68126,660 51.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5336,818 37.2%   
Profit after tax Rs m11,14819,843 56.2%  
Gross profit margin %27.441.1 66.9%  
Effective tax rate %18.525.6 72.4%   
Net profit margin %20.728.5 72.6%  
BALANCE SHEET DATA
Current assets Rs m25,77967,906 38.0%   
Current liabilities Rs m12,80817,284 74.1%   
Net working cap to sales %24.172.6 33.1%  
Current ratio x2.03.9 51.2%  
Inventory Days Days2310 246.7%  
Debtors Days Days2878 0.3%  
Net fixed assets Rs m41,31145,963 89.9%   
Share capital Rs m393531 74.0%   
"Free" reserves Rs m50,88392,415 55.1%   
Net worth Rs m51,27692,946 55.2%   
Long term debt Rs m1,9990-   
Total assets Rs m67,090113,869 58.9%  
Interest coverage x86.41,270.5 6.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 131.3%   
Return on assets %16.917.4 96.6%  
Return on equity %21.721.3 101.8%  
Return on capital %26.028.7 90.5%  
Exports to sales %66.80-   
Imports to sales %12.718.8 67.4%   
Exports (fob) Rs m36,020NA-   
Imports (cif) Rs m6,84513,127 52.1%   
Fx inflow Rs m36,02058,877 61.2%   
Fx outflow Rs m6,84513,341 51.3%   
Net fx Rs m29,17545,536 64.1%   
CASH FLOW
From Operations Rs m14,63419,469 75.2%  
From Investments Rs m-8,388751 -1,116.5%  
From Financial Activity Rs m-5,974-349 1,712.3%  
Net Cashflow Rs m26219,872 1.3%  

Share Holding

Indian Promoters % 69.1 51.9 133.0%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.8 36.8 48.3%  
FIIs % 6.0 18.5 32.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 48.1 63.2%  
Shareholders   106,437 309,397 34.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 23, 2022 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - DECCAN HEALTH CARE COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS